Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000378:metabolism*; D006258:Head and Neck Neoplasms / Q000378:metabolism* / Q000628:therapy*; D006801:Humans; D009363:Neoplasm Proteins / Q000378:metabolism*; D011379:Prognosis; D020794:Receptor Protein-Tyrosine Kinases / Q000378:metabolism; D017211:Treatment Failure
D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D009363:Neoplasm Proteins; D066246:ErbB Receptors; D020794:Receptor Protein-Tyrosine Kinases